Morgan Stanley Second Sight Medical Products Inc Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$1.22 - $2.57 $403,251 - $849,472	-330,534 Reduced 58.69%	232,673 $472,000
Q2 2022 Aug 15, 2022	SELL	$1.22 - $2.57 $403,251 - $849,472	-330,534 Reduced 58.69%	232,673 $472,000
Q1 2022 Oct 27, 2022	BUY	$1.16 - $1.83 $383,419 - $604,877	330,534 Added 142.06%	563,207 $805,000
Q1 2022 May 13, 2022	SELL	$1.16 - $1.83 $551,034 - $869,304	-475,030 Reduced 45.75%	563,207 $805,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.41 $1.45 Million - $3.03 Million	889,432 Added 597.72%	1,038,237 $1.69 Million
Q3 2021 Nov 15, 2021	BUY	$3.11 - $4.75 $462,783 - $706,823	148,805 New	148,805 $474,000

Ticker EYES
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,136,400
Market Cap $54.4M
Description
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.